
北美 GMP 测试服务市场预测至 2028 年 - 按服务类型(产品验证测试、生物分析服务、包装和保质期测试及其他服务)和最终用户(制药和生物制药公司以及医疗器械)划分的 COVID-19 影响和区域分析公司)
No. of Pages: 117 | Report Code: BMIRE00027773 | Category: Life Sciences
No. of Pages: 117 | Report Code: BMIRE00027773 | Category: Life Sciences
医疗器械行业正在为医疗技术的发展做出贡献,这些技术有可能加强对各种疾病的诊断和治疗,并支持医疗器械的有效制造。设备。医疗器械行业生产的设备范围从外科口罩等常见用品到高科技成像设备。胰岛素输送系统、血糖监测仪、制氧机和雾化器等医疗设备越来越多地用于家庭诊断和治疗一些疾病。这些设备与患者的电子病历、可穿戴设备、手机和远程医疗平台集成,为增强临床和运营决策提供重要见解。根据PRODSMART提供的数据,2020年医疗器械制造业价值约为42亿美元。慢性病发病率上升和老年人口增长是预计影响医疗器械制造业进展的主要因素。未来几年的医疗器械行业。智能小工具、智能传感器和其他轻型通信设备促进了具有医疗物联网 (IoMT) 系统的医疗设备的操作。此类创新可帮助医疗保健公司改善患者治疗效果、降低成本并提高效率。 GMP 在医疗器械的制造中非常重要,因为它们确保向公众发布的任何产品的质量、安全性、纯度和强度水平。遵守这些做法有助于制造商防止不利影响、产品召回和缺陷,这些可能会导致未来代价高昂的责任诉讼。由于质量控制和一致的测试环境对于成功的制造周期至关重要,因此对 GMP 的关注日益增加,以避免产品污染、故障和质量偏差。因此,通过建立以 GMP 为主导的强大、规范的运营管理体系,医疗器械制造商可以开发大量优质产品,同时减少代价高昂的延误。因此,上述因素正在支撑北美GMP检测服务市场的增长。
北美 GMP 测试服务市场分为美国、加拿大和墨西哥。 2021年,美国占据最大市场份额。不断增长的制药业以及开发新药和医疗器械的需求不断增加,正在加速北美GMP测试服务市场的增长。此外,政府卫生支出的增加以及医疗产品质量保证外包活动的增加正在推动该地区市场的扩张。美国在北美 GMP 检测服务市场中占有重要份额。该国的市场增长归因于政府医疗保健支出的增加、制药行业的持续发展以及各种传染病对新药的需求不断增长。
北美 GMP 测试服务市场根据服务类型、最终用户进行细分和国家。根据服务类型,市场分为产品验证测试、生物分析服务、包装和服务。保质期检测等服务类型。 2022年,产品验证测试领域占据最大市场份额。
根据最终用户,北美GMP测试服务市场分为制药和生物制药公司以及医疗器械公司。到2022年,制药和生物制药公司细分市场将占据更大的市场份额。
北美GMP测试服务市场按国家划分,分为美国、加拿大和墨西哥。 2022 年,美国将占据市场份额。
Eurofins Scientific;阿尔马克集团;天祥集团有限公司;药明康德;赛多利斯公司;北美科学协会;尼尔森实验室有限责任公司;波士顿分析;佩斯分析服务;和 Thermo Fisher Scientific Inc. (PPD Inc.) 是北美 GMP 测试服务市场的领先公司之一。
Strategic insights for North America GMP Testing Service involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 846.02 Million |
Market Size by 2028 | US$ 1,260.96 Million |
Global CAGR (2022 - 2028) | 6.9% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 服务类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America GMP Testing Service refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America GMP Testing Service Market is valued at US$ 846.02 Million in 2022, it is projected to reach US$ 1,260.96 Million by 2028.
As per our report North America GMP Testing Service Market, the market size is valued at US$ 846.02 Million in 2022, projecting it to reach US$ 1,260.96 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The North America GMP Testing Service Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America GMP Testing Service Market report:
The North America GMP Testing Service Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America GMP Testing Service Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America GMP Testing Service Market value chain can benefit from the information contained in a comprehensive market report.